14 March 2018 – Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market announces that an application (the “Application”) has been made to the London Stock Exchange for 200,000 ordinary shares of one pence each (“Ordinary Shares”) to be admitted to trading on AIM (the “Admission”). All these Ordinary Shares are being reserved under an extension to an existing block listing and will be issued as required in order to satisfy the exercise of share options pursuant to the 2007 Share Option Plan.
It is expected that Admission of these Ordinary Shares will become effective on 16 March 2018. When issued, the Ordinary Shares will be credited as fully paid and will rank pari passu in all respects with the existing Ordinary Shares.
For further information, please contact:
- +44 (0)20 7418 8900
- Dan Webster
- George Sellar
- Nicole McDougall
- +44 (0)208 004 4218
- Caroline Forde
- Hilary Buchanan
- Robyn Fisher
Craneware (AIM: CRW.L) is the market leader in software and supporting services that help healthcare providers improve margins so they can invest in quality patient outcomes. The Company’s flagship solution, Chargemaster Toolkit®, has earned the KLAS No.1 ranking in Revenue Cycle – Chargemaster Management since 2006 and is part of Craneware’s value cycle management suite, which includes patient engagement, charge capture and pricing, claims analysis, revenue recovery and retention, and cost analytics solutions.
Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta, Boston and Pittsburgh employing over 250 staff.
Learn more at www.craneware.com.